ABL Diagnostics: Trading & Distribution Growth Amid Market Volatility
ABL Diagnostics: NYSE‑listed trading firm hits 52‑week highs at €5 while a 42.18 P/E reflects premium growth expectations and market resilience.
2 minutes to read
ABL DIAGNOSTICS
ABL Diagnostics: Leading Molecular Diagnostics & PCR Solutions in Europe
ABL Diagnostics, a leader in molecular biology assays and PCR solutions, offers NGS, sequencing, and lab automation tools, driving innovation in global diagnostics.
2 minutes to read